# ED Management of Severe Hyperglycemia: A Clinical Trial

> **NCT02478190** · NA · COMPLETED · sponsor: **Hennepin Healthcare Research Institute** · enrollment: 110 (actual)

## Conditions studied

- Hyperglycemia
- Diabetes Mellitus
- Complications of Diabetes Mellitus
- Diabetes-Related Complications
- Diabetes Mellitus, Type 2

## Interventions

- **OTHER:** Tight control: goal glucose 350 mg/dL or lower
- **OTHER:** Loose control: goal glucose 600 mg/dL or lower

## Key facts

- **NCT ID:** NCT02478190
- **Lead sponsor:** Hennepin Healthcare Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2018-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02478190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02478190, "ED Management of Severe Hyperglycemia: A Clinical Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02478190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*